methoprene has been researched along with Communicable-Diseases--Emerging* in 2 studies
2 other study(ies) available for methoprene and Communicable-Diseases--Emerging
| Article | Year |
|---|---|
Suppressing Aedes albopictus, an emerging vector of dengue and chikungunya viruses, by a novel combination of a monomolecular film and an insect-growth regulator.
The Asian tiger mosquito Aedes albopictus (Skuse) is rapidly increasing its global range and importance in transmission of chikungunya and dengue viruses. We tested pellet formulations of a monomolecular film (Agnique) and (S)-methoprene (Altosid) under laboratory and field conditions. In the laboratory, Agnique provided 80% control for 20 days, whereas Altosid, in combination with Agnique, provided 80% control for > 60 days. During field trials, the 1:1 pellet ratio of combined products provided > 95% control for at least 32 days and 50% control for at least 50 days. Altosid remained effective after a 107-day laboratory-induced drought, suggesting that the product serves as a means of control during drought conditions and against spring broods in temperate regions. Agnique and Altosid, when used in tandem for cryptic, difficult-to-treat locations, can provide long-term control of Ae. albopictus larvae and pupae. The possible additive or synergistic effects of the combined products deserve further investigation. Topics: Aedes; Alphavirus Infections; Animals; Chikungunya virus; Communicable Diseases, Emerging; Dengue; Humans; Insect Vectors; Insecticides; Juvenile Hormones; Larva; Membranes, Artificial; Methoprene; Mosquito Control; Pupa | 2010 |
Larvicide debate marks start of another West Nile virus summer.
Topics: Canada; Communicable Disease Control; Communicable Diseases, Emerging; Health Education; Humans; Insecticides; Methoprene; Mosquito Control; National Health Programs; New York City; Seasons; West Nile Fever | 2003 |